Importance Between 40% and 50% of women in Western countries use complementary
therapies to manage menopausal symptoms. Objective To determine the association of …

A systematic literature search revealed 35 clinical studies and one meta-analysis comprising
43,759 women, of which 13,096 were treated with isopropanolic Cimicifuga racemosa …

Women's health is an imminent concern worldwide, but it remains an ignored segment of
research in most developing countries, and is yet to take the center stage in even developed …

Endocrine therapy in breast cancer survivors can cause severe 'climacteric'symptoms, which
may compromise therapy adherence. To determine whether such symptoms can be treated …

Background Menopausal symptoms severely reduce the quality of life of post-menopausal
women worldwide. Nutraceuticals are widely prescribed as a viable and safer alternative …

Cimicifuga racemosa (CR) extracts are important worldwide as therapy for menopausal
symptoms. The first medicinal product from CR has been available since 1956 (Germany …

Context Sleep disturbances are a core symptom of menopause, which refers to the
permanent cessation of menstrual periods. Nutritional interventions may alleviate …

Background: Menopause is an important physiological phenomenon in women's lives.
Women's concern about taking the hormone treatment to ease menopausal symptoms is …

A reduction in estrogen levels in the perimenopausal and postmenopausal periods causes
various symptoms in women, such as hot flushes, sweats, depression, anxiety, and …

Weight gain is a frequent problem in perimenopausal and postmenopausal women.
Cimicifuga racemosa (CR) is a popular treatment option for menopausal symptoms. The aim …